Endocrinology News and Research

Latest Endocrinology News and Research

Kaiser Permanente study: Snapshot of the prevalence of extreme obesity in younger children

Extreme obesity is affecting more children at younger ages, with 12 percent of black teenage girls, 11.2 percent of Hispanic teenage boys, 7.3 percent of boys and 5.5 percent of girls now classified as extremely obese, according to a Kaiser Permanente study of 710,949 children and teens that appears online in the Journal of Pediatrics.

19 Mar 2010

Survey unveils impact of gene regulation on human health

Researchers are only beginning to understand how individual variation in gene regulation can have a lasting impact on one's health and susceptibility to certain diseases. Now, an ambitious survey of the human genome has identified differences in the binding of master regulators called transcription factors to DNA that affect how genes are expressed in different people.

19 Mar 2010

As the nation focuses on quality and cost of health care, AMA-convened PCPI celebrates milestone and looks to future

Celebrating its 10 year anniversary today at its meeting in the nation’s capital, the AMA-convened Physician Consortium for Performance Improvement (PCPI) highlighted its achievements to date and took a proactive look at future efforts to measure and improve the quality of patient care.

18 Mar 2010

Mrs. Obama on childhood obesity

Last month First Lady Michelle Obama launched a programme called “Let’s Move” aiming at reducing and eradicating the childhood obesity epidemic in the existing generation so that the nation as a whole attains a healthy adulthood in the coming decades.

18 Mar 2010

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

Humedica, a next-generation clinical informatics company, and Anceta, the healthcare informatics subsidiary of the American Medical Group Association, today announced the launch of Humedica MinedShare™ Ambulatory as well as AMGA’s Anceta Collaborative Data Warehouse at the AMGA 2010 Annual Conference, taking place now through March 20 in New Orleans.

18 Mar 2010

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences. These important findings were presented at the American College of Cardiology annual meeting, (ACC 2010) in Atlanta and published on-line in the prestigious journal The Lancet.

18 Mar 2010

Evaluating all Medicare plan options can reduce healthcare costs

Nearly 8 million former workers have disabilities so severe that they rely on Social Security Disability Insurance benefits, and an estimated 3.3 million more will apply for disability benefits this year. For these people and others suffering from serious conditions and disabilities, taking the right steps quickly to manage costs is essential for their financial and health well-being, according to Allsup, a nationwide provider of Social Security disability representation and Medicare plan selection services.

18 Mar 2010

Having lower TSH levels while taking thyroxine replacement is not detrimental to health, says study

New research shows that it may be safe for patients taking thyroxine replacement to have low but not suppressed thyroid stimulating hormone (TSH) levels. The research, presented at the Society for Endocrinology BES meeting in Manchester, shows for the first time that it may be safe for patients to take slightly higher doses of thyroxine than are currently recommended.

18 Mar 2010

NexACT technology demonstrates ability to deliver Taxol subcutaneously

NexMed, Inc., a specialty CRO and a developer of products based on the NexACT® technology, today announced that pre-clinical results from the research and development group at its Bio-Quant subsidiary have successfully demonstrated the ability of the NexACT technology to deliver insulin and other large molecule drugs such as Taxol subcutaneously, in a depot-like fashion (or slow release) over a 24 hour period from a single injection.

18 Mar 2010

Expectant mothers’ spatial memory ability reduces during later stages of pregnancy

New research has found that pregnant women's ability to remember the position of objects previously seen is reduced as pregnancy progresses. These findings will be presented this week at the annual Society for Endocrinology BES conference in Manchester.

18 Mar 2010

OrbusNeich's Genous Bio-engineered R stent demonstrates long term clinical efficacy

OrbusNeich today announced that 12 month follow up data from real world patients demonstrated long term clinical efficacy of the company's Genous Bio-engineered R stent.

18 Mar 2010

New dental health awareness campaign targeting Massachusetts seniors

Universal Dental Plan newly launched its first ever dental health awareness campaign targeting Massachusetts seniors. Based on a large body of major medical research, the organization built its 2010 keynote outreach initiative around three main objectives -- to alert seniors on the high costs and acute health risks of delayed dentistry, educate them on easy and actionable ways to keep major dental problems at bay, and introduce them to a convenient solution that makes dentistry affordable for all.

18 Mar 2010

New specialty service at Montefiore Medical Center helps patients with drug allergies

A Westchester patient takes aspirin for pain, but develops rashes and hives. A Bronx patient with a gastrointestinal problem caused by bacteria is prescribed penicillin, then passes out. A Bronx woman is given a contrast dye for an internal diagnostic exam, then her skin peels off.

18 Mar 2010

High plasma selenium concentrations linked to lower occurrence of dysglycemia in elderly men

The role of selenium in diabetes has been controversial, with some studies suggesting that it raises diabetes risk and others finding that it is protective. Now, research published in BioMed Central's open access journal Nutrition and Metabolism, has shown that, for men, high plasma selenium concentrations are associated with a lower occurrence of dysglycemia.

18 Mar 2010

AMGA to present Medical Group Preeminence Award to HealthTexas Provider Network

The American Medical Group Association announced it will present the Medical Group Preeminence Award on March 20 to HealthTexas Provider Network, an affiliate of Baylor Health Care System based in the Dallas/Fort Worth area of Texas. The presentation will take place at the AMGA 2010 Annual Conference, being held March 18-20 at the New Orleans Marriott.

18 Mar 2010

Taking dietary supplements for adrenal fatigue may do more harm than good

Taking vitamins or supplements to treat "adrenal fatigue" may do more harm than good, says Todd Nippoldt, M.D., a Mayo Clinic expert in hormone disorders affecting the adrenal glands.

18 Mar 2010

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company’s nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.

18 Mar 2010

ONGLYZA-metformin combination: FDA accepts NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.

17 Mar 2010

FDA approves Medtronic's MiniMed Paradigm integrated diabetes management system

Medtronic, Inc. today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, the next generation of the industry’s only integrated diabetes management system (insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software).

17 Mar 2010

Research data: WTC collapse caused potentially dangerous heart problems in responders on-site

Researchers from Mount Sinai School of Medicine are presenting more than 20 ground-breaking studies at the American College of Cardiology 59th annual scientific session (ACC.10) in Atlanta. Their research includes data showing that the World Trade Center collapse has caused potentially dangerous heart problems in responders on-site.

17 Mar 2010

Endocrinology News and Research

Latest Endocrinology News and Research

Kaiser Permanente study: Snapshot of the prevalence of extreme obesity in younger children

Survey unveils impact of gene regulation on human health

As the nation focuses on quality and cost of health care, AMA-convened PCPI celebrates milestone and looks to future

Mrs. Obama on childhood obesity

Humedica, Anceta unveil health care data solutions at AMGA 2010 Annual Conference

CYPHER Sirolimus-eluting Coronary Stent demonstrates efficacy advantages over Medtronic's Endeavor

Evaluating all Medicare plan options can reduce healthcare costs

Having lower TSH levels while taking thyroxine replacement is not detrimental to health, says study

NexACT technology demonstrates ability to deliver Taxol subcutaneously

Expectant mothers’ spatial memory ability reduces during later stages of pregnancy

OrbusNeich's Genous Bio-engineered R stent demonstrates long term clinical efficacy

New dental health awareness campaign targeting Massachusetts seniors

New specialty service at Montefiore Medical Center helps patients with drug allergies

High plasma selenium concentrations linked to lower occurrence of dysglycemia in elderly men

AMGA to present Medical Group Preeminence Award to HealthTexas Provider Network

Taking dietary supplements for adrenal fatigue may do more harm than good

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

ONGLYZA-metformin combination: FDA accepts NDA for review

FDA approves Medtronic's MiniMed Paradigm integrated diabetes management system

Research data: WTC collapse caused potentially dangerous heart problems in responders on-site

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Endocrinology News and Research

Latest Endocrinology News and Research

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Newsletters you may be interested in